1. Potential association factors for developing effective peptide-based cancer vaccines
   Chongming Jiang et al, 2022, Frontiers in Immunology CrossRef
2. Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer
   Koichi Takayama et al, 2016, Journal of Immunology Research CrossRef
3. Prospect and progress of personalized peptide vaccinations for advanced cancers
   Shinjiro Sakamoto et al, 2016, Expert Opinion on Biological Therapy CrossRef
4. Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients
   Kayoko Waki et al, 2020, Cancer Immunology, Immunotherapy CrossRef